NCT00807287

Brief Summary

In patients with high gastric residual volumes jejunal feeding is recommended. Jejunal feeding tubes can be placed in different ways. The endoscopic technique yields a success rate between 90 and 98% for a correct jejunal placement. However, it requires endoscopic equipment and trained staff. In contrast in small uncontrolled trials different unguided techniques resulted in success rates up to 75%, only. In this prospective randomized trial the success rate of a correct jejunal placement with the endoscopic technique is compared with the unguided frictional technique. The investigators hypothesize that the success rate of the unguided frictional placement method will be lower than the success rate of the endoscopic method.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2005

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2005

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2006

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2006

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

December 10, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 11, 2008

Completed
Last Updated

December 11, 2008

Status Verified

December 1, 2008

Enrollment Period

1 year

First QC Date

December 10, 2008

Last Update Submit

December 10, 2008

Conditions

Keywords

jejunal tube placement

Outcome Measures

Primary Outcomes (1)

  • Success rate of correct jejunal placement

    24h

Secondary Outcomes (2)

  • Duration of jejunal tube placement (initiation of jejunal tube placement till correct jejunal placement

    24h

  • Adverse effects of tube placement and adverse side effects of jejunal tubes during the ICU stay

    ICU-stay

Study Arms (2)

1

EXPERIMENTAL

Placement of jejunal feeding tube using the unguided frictional method

Procedure: Jejunal tube placement using the unguided frictional method

2

ACTIVE COMPARATOR

Jejunal tube placement using the endoscopic method

Procedure: Jejunal tube placement using the endoscopic method

Interventions

The self-advancing nasal jejunal feeding tube has small alternating cilia-like plastic flaps to help to advance it into the small bowel via peristalsis. The tube is placed in the stomach (50-60 cm mark). Then the tube is left in place for 1 hour to allow the patient's peristalsis to advance the tube by catching its small plastic tabs. Thereafter, the tube is manually advanced 10 cm every hour until the 100 cm mark of length is reached. To improve peristalsis, 10mg metoclopramide i.v. and 200mg erythromycin i.v. 15 minutes before the procedure are administered.

Also known as: Tiger Tube TM (Cook® Medical Inc., Bloomington, USA)
1

Jejunal feeding tubes are placed using endoscopy

Also known as: Freka® Trelumina (Fresenius Kabi AG, Bad Homburg, Germany)
2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Intubated and mechanically ventilated
  • Intolerance of intragastric enteral nutrition: defined as high gastric residual volumes (≥ 250ml / 24 hours) and/or repeated vomiting.

You may not qualify if:

  • Contraindication for enteral nutrition or gastric endoscopy
  • Previous upper gastrointestinal surgery
  • Signs of active gastric bleeding
  • Severe nasopharyngeal injuries or stenosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Vienna

Vienna, Vienna, 1090, Austria

Location

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Ulrike Holzinger, MD

    Medical University of Vienna

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 10, 2008

First Posted

December 11, 2008

Study Start

February 1, 2005

Primary Completion

February 1, 2006

Study Completion

April 1, 2006

Last Updated

December 11, 2008

Record last verified: 2008-12

Locations